126 related articles for article (PubMed ID: 18284001)
1. Dosing of antimicrobial agents in critically-ill patients with acute kindey injury and continuous venvenous haemofiltration.
Bouman CS
Acta Clin Belg; 2007; 62 Suppl 2():365-70. PubMed ID: 18284001
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial dosing strategies in critically ill patients with acute kidney injury and high-dose continuous veno-venous hemofiltration.
Bouman CS
Curr Opin Crit Care; 2008 Dec; 14(6):654-9. PubMed ID: 19023912
[TBL] [Abstract][Full Text] [Related]
3. Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing.
Bouman CS; van Kan HJ; Koopmans RP; Korevaar JC; Schultz MJ; Vroom MB
Intensive Care Med; 2006 Dec; 32(12):2013-9. PubMed ID: 17043848
[TBL] [Abstract][Full Text] [Related]
4. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.
Jiang SP; Xu YY; Ping-Yang ; Wu WF; Zhang XG; Lu XY; Xiao YH; Liang WF; Chen J
Eur J Intern Med; 2014 Dec; 25(10):930-5. PubMed ID: 25153537
[TBL] [Abstract][Full Text] [Related]
5. Gentamicin pharmacokinetics during continuous venovenous hemofiltration in critically ill septic patients.
Petejova N; Zahalkova J; Duricova J; Kacirova I; Brozmanova H; Urbanek K; Grundmann M; Martinek A
J Chemother; 2012 Apr; 24(2):107-12. PubMed ID: 22546767
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis.
Bellmann R; Egger P; Gritsch W; Bellmann-Weiler R; Joannidis M; Dunzendorfer S; Wiedermann ChJ
Acta Med Austriaca; 2002; 29(3):112-6. PubMed ID: 12168566
[TBL] [Abstract][Full Text] [Related]
8. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?
Blot S; Lipman J; Roberts DM; Roberts JA
Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.
Jamal JA; Mat-Nor MB; Mohamad-Nor FS; Udy AA; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jan; 45(1):41-5. PubMed ID: 25455853
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction in critically ill patients: the effect of haemofiltration.
Cardigan R; McGloin H; Mackie I; Machin S; Singer M
Intensive Care Med; 1998 Dec; 24(12):1264-71. PubMed ID: 9885878
[TBL] [Abstract][Full Text] [Related]
12. Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients.
Traunmüller F; Schenk P; Mittermeyer C; Thalhammer-Scherrer R; Ratheiser K; Thalhammer F
J Antimicrob Chemother; 2002 Jan; 49(1):129-34. PubMed ID: 11751776
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of levofloxacin during continuous veno-venous hemofiltration.
Hansen E; Bucher M; Jakob W; Lemberger P; Kees F
Intensive Care Med; 2001 Feb; 27(2):371-5. PubMed ID: 11396281
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
Boucher BA; Hudson JQ; Hill DM; Swanson JM; Wood GC; Laizure SC; Arnold-Ross A; Hu ZY; Hickerson WL
Pharmacotherapy; 2016 Dec; 36(12):1229-1237. PubMed ID: 27862103
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapy.
Kuang D; Verbine A; Ronco C
Clin Nephrol; 2007 May; 67(5):267-84. PubMed ID: 17542336
[TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
Janssen PK; Foudraine NA; Burgers DM; Neef K; le Noble JL
Ther Drug Monit; 2016 Dec; 38(6):699-705. PubMed ID: 27494946
[TBL] [Abstract][Full Text] [Related]
17. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
Roberts DM; Roberts JA; Roberts MS; Liu X; Nair P; Cole L; Lipman J; Bellomo R;
Crit Care Med; 2012 May; 40(5):1523-8. PubMed ID: 22511133
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration.
Jamal JA; Roberts DM; Udy AA; Mat-Nor MB; Mohamad-Nor FS; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jul; 46(1):39-44. PubMed ID: 25881872
[TBL] [Abstract][Full Text] [Related]
19. Phenytoin removal by continuous venovenous hemofiltration.
Oltrogge KM; Peppard WJ; Saleh M; Regner KR; Herrmann DJ
Ann Pharmacother; 2013 Sep; 47(9):1218-22. PubMed ID: 24259740
[TBL] [Abstract][Full Text] [Related]
20. Single-dose pharmacokinetics of ofloxacin during continuous venovenous hemofiltration in critical care patients.
Fuhrmann V; Schenk P; Mittermayer C; El Menyawi I; Ratheiser K; Thalhammer F
Am J Kidney Dis; 2003 Aug; 42(2):310-4. PubMed ID: 12900813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
